|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.15 USD | -1.38% |
|
0.00% | +11.70% |
| 07-13 | GSK posts encouraging data for bowel cancer treatment Jemperli | AN |
| 06-29 | AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from Russell 3000E Growth Benchmark | CI |
| Market Cap | 1.6B 1.41B 1.31B 1.2B 2.26B 155B 2.3B 15.57B 6.08B 75.88B 6.02B 5.89B 263B | P/E 2026 * |
-219x | P/E 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.51B 1.33B 1.24B 1.13B 2.13B 146B 2.17B 14.68B 5.73B 71.52B 5.67B 5.55B 248B | EV / Sales 2026 * |
16x | EV / Sales 2027 * | 8.55x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: AnaptysBio, Inc.
| 1 day | -1.38% | ||
| Current month | -19.78% | ||
| 1 month | -8.88% | ||
| 3 months | +5.62% | ||
| 6 months | +13.90% | ||
| Current year | +11.70% |
| 1 week | 49.71 |  | 59.09 |
| 1 month | 49.71 | | 70.91 |
| Current year | 42 | | 73.3 |
| 1 year | 17.11 | | 73.3 |
| 3 years | 12.21 | | 73.3 |
| 5 years | 12.21 | | 73.3 |
| 10 years | 10 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 46 | 2022-03-20 |
| Director of Finance/CFO | 42 | 2026-05-10 | |
Benjamin Stone
PRN | Corporate Officer/Principal | 35 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 79 | 2015-06-29 |
John Schmid
BRD | Director/Board Member | 63 | 2015-06-29 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 2021-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/15/26 | Fiscal year | Chairman | 12,060 | 0.0414% | ||
| 6/15/26 | Fiscal year | Director | 12,060 | 0.0414% | ||
| 6/15/26 | Fiscal year | Director | 12,060 | 0.0414% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | 0.00% | +100.56% | +198.84% | 1.63B | |
| -1.92% | -1.57% | +48.70% | +84.37% | 55.92B | |
| +0.93% | +7.22% | +64.67% | +63.56% | 56.67B | |
| -2.97% | -2.44% | -22.05% | -17.74% | 23.28B | |
| -0.46% | -0.50% | +3.36% | +407.21% | 23.28B | |
| -0.36% | -0.56% | +36.00% | -3.93% | 20.54B | |
| -1.34% | -0.63% | +29.60% | -32.53% | 17.78B | |
| -1.44% | -1.63% | +37.07% | +589.93% | 15.9B | |
| -1.30% | -9.92% | +160.67% | +284.37% | 14.64B | |
| -0.50% | -0.56% | +21.96% | +181.21% | 13.99B | |
| Average | -1.07% | +0.56% | +48.05% | +175.53% | 24.36B | |
| Weighted average by Cap. | -0.89% | +1.47% | +43.64% | +135.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 94.28M 82.95M 77.09M 70.78M 133M 9.1B 135M 916M 358M 4.46B 354M 346M 15.44B | 153M 135M 125M 115M 216M 14.79B 220M 1.49B 581M 7.25B 575M 563M 25.09B |
| Net income | -7.47M -6.57M -6.11M -5.61M -10.52M -721M -10.7M -72.52M -28.32M -353M -28.03M -27.43M -1.22B | 129M 113M 105M 96.64M 181M 12.43B 184M 1.25B 488M 6.09B 483M 473M 21.08B |
| Net Debt | -92.22M -81.15M -75.41M -69.24M -130M -8.9B -132M -896M -350M -4.36B -346M -339M -15.11B | -293M -258M -240M -220M -413M -28.29B -420M -2.85B -1.11B -13.87B -1.1B -1.08B -48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$54.15 | -1.38% | 485,707 |
| 26-07-23 | US$54.91 | +4.37% | 674,422 |
| 26-07-22 | US$52.61 | -2.14% | 986,959 |
| 26-07-21 | US$53.76 | +6.90% | 1,272,000 |
| 26-07-20 | US$50.29 | -13.29% | 1,248,535 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANAB Stock
Select your edition
All financial news and data tailored to specific country editions
